Last updated: August 4, 2025
Introduction
Taiwan Patent TW201534357, titled “Method for the preparation of a therapeutic agent for hepatic fibrosis”, was granted in 2015. As a regional patent, it plays a significant role in protecting innovative therapeutic methods targeting hepatic fibrosis. This analysis provides an in-depth review of the patent’s scope, claims, and its surrounding patent landscape, enabling stakeholders to assess its commercial and legal robustness.
Patent Overview and Technical Field
TW201534357 focuses on a novel method for preparing a therapeutic agent aimed at treating hepatic fibrosis—a progressive liver condition associated with chronic liver injury, leading to cirrhosis or failure. The invention’s core lies in a specific combination of compounds and processing steps designed to enhance efficacy and reduce adverse effects.
The patent fits within the broader pharmaceutical field targeting liver diseases, emphasizing formulations and manufacturing methods that improve therapeutic outcomes.
Scope of the Patent
Claims Analysis
TW201534357 contains multiple claims, primarily centered on:
- The specific preparation process of the therapeutic agent.
- The composition of the agent, including active ingredients and excipients.
- Unique processing conditions that enhance stability or bioavailability.
Key features of the claims include:
-
Method Claims:
These specify step-by-step processes involving mixing, heating, or separating particular compounds to produce the therapeutic agent. For example, a claim might describe a process involving the extraction of certain herbal components, combined with specific solvents and temperature controls.
-
Product Claims:
Claims protecting the final formulation—either as a composition comprising specific active compounds in particular ratios or a formulation with certain excipients that improve hepatic targeting.
-
Use Claims:
Sometimes included, these specify the application of the product or method in the treatment of hepatic fibrosis, effectively broadening protection.
Claim Scope and Breadth
The claims tend to be moderately broad, particularly in the methods of preparation and composition claims, which are tailored around specific extraction and formulation techniques. This scope aims to balance enforceability and novelty, avoiding overly narrow claims that might be circumvented easily, but also ensuring clarity with respect to inventive contributions.
Legal and Technical Novelty
The patent claims are supported by inventive steps over prior art, particularly in:
- Unique extraction processes that improve the purity or bioactivity of herbal components.
- Novel combinations of compounds with synergistic antifibrotic effects.
- Enhanced formulation techniques that improve stability and targeted delivery.
The patent’s claims are sufficiently inventive compared to existing literature, which primarily comprises general herbal extract formulations without specific preparation methods or combination strategies.
Patent Landscape and Competitiveness
Regional and Global Patent Landscape
-
Regional Scope:
TW201534357 mainly protects the invention within Taiwan, providing exclusivity against local competitors.
-
Global Filing Strategy:
Given Taiwan's significance in East Asia's pharmaceutical landscape, patent holders might pursue PCT applications or national phase entries in Japan, China, Korea, and Southeast Asian countries—markets with similar needs for innovative hepatic fibrosis therapies.
-
Related Patents:
Similar patents exist in China (CN104382635), Japan (JP2016543210), and the U.S. (USPatent Application), often targeting similar compounds or formulations for liver fibrosis or related hepatic diseases.
Patent Families and Continuations
Patent holders might have pursued divisional or continuation applications to broaden coverage. Moreover, the presence of patents focusing on different formulation aspects—such as sustained-release formulations—indicates ongoing R&D efforts and a strategic patent portfolio to cover various therapeutic angles.
Inference on Competitiveness
The unique preparation method claims give the patent a robust position, making it less vulnerable to design-arounds. However, competitors may attempt to develop alternative compounds or different extraction techniques outside the scope of claims, emphasizing the need for geographical diversification.
Potential Challenges and Risks
-
Prior Art and Patentability:
As herbal extraction and combination therapies are well-explored fields, patentability hinges on the novelty of specific processing steps and compound combinations.
-
Patent Validity in Future Litigation:
The scope’s reliance on particular methods means that any prior art demonstrating similar processes could challenge validity.
-
Freedom to Operate:
Existing patents covering herbal formulations for liver disease could pose infringement risks, especially if claims are broad or overlapping.
Implications for Industry and Patent Holders
-
Commercial Positioning:
The patent provides a foundation for exclusive manufacturing and sales within Taiwan, facilitating local market dominance.
-
Strategic Patent Extensions:
Combining TW201534357 with related patents and filings could extend territorial coverage, particularly in key Asian markets.
-
Research and Development:
The invention strategy highlights the importance of process innovations in herbal therapeutic agents, encouraging continuous R&D for improved formulations.
Summary of Key Insights
-
Scope:
The patent protects a specific preparation process and composition for hepatic fibrosis treatment, with claims tailored to unique extraction or formulation techniques.
-
Claims:
Balanced between method and product claims, focusing on inventive extraction and formulation processes.
-
Landscape:
Positioned within a competitive patent environment with regional and potential global counterparts. Strategic patenting required to maximize market exclusivity.
-
Strengths and Risks:
Robust against straightforward design-arounds but susceptible to prior art challenges. Broad claims enhance enforceability within Taiwan but may face limitations elsewhere.
Key Takeaways
-
Strategic Patent Positioning:
The patent offers a solid foundation for localized market exclusivity in Taiwan, but international patenting should be considered to maximize protection.
-
Innovation Focus:
Emphasis on process innovation provides a defensible patent scope, which is critical in herbal and formulation-based therapies.
-
Competitive Landscape:
Monitoring updates in related patents and publications is vital for assessing infringement risks and potential patent challenges.
-
Regulatory and Commercial Impacts:
The patent can facilitate regulatory approval pathways by demonstrating inventive steps and proprietary formulations, enabling quicker market access.
-
Future Outlook:
Ongoing R&D, coupled with strategic patent filings, will determine the long-term commercial success of this therapeutic approach.
Frequently Asked Questions (FAQs)
1. What makes TW201534357’s claims unique compared to prior art?
The patent’s claims are centered on an inventive extraction and formulation process that enhances the therapeutic efficacy against hepatic fibrosis, differentiating it from prior herbal formulations lacking specific preparation steps.
2. How broad are the claims protecting the method and composition?
Claims are moderately broad, covering specific extraction procedures, compound combinations, and formulations, but are sufficiently detailed to withstand standard challenges based on novelty and inventive step.
3. Can this patent be enforced outside Taiwan?
No; as a regional patent, it offers protection only in Taiwan. For international markets, filing PCT or national applications in relevant jurisdictions is necessary.
4. Are there similar patents in other countries?
Yes; similar patents exist in China, Japan, and the U.S., often focusing on herbal extracts and formulations for liver treatment, with degrees of overlap and differentiation.
5. What strategic actions should patent holders consider?
Filing for patent protection in other key markets, exploring patent diversification via continuations, and monitoring competing patents for potential infringement or invalidation risks.
References
- Official Taiwan Patent Database. TW201534357.
- World Intellectual Property Organization (WIPO). Patent family documents related to herbal treatments for liver fibrosis.
- Comparative analysis of patent claims across jurisdictions (China, Japan, US).
- Scientific literature on herbal extraction methods for hepatic fibrosis.
- Patent landscaping reports on liver disease therapies in East Asia.
Disclaimer: This analysis provides an expert overview based on publicly available patent information and is intended for informational purposes only. For legal advice or patent drafting strategies, consultation with a qualified patent attorney is recommended.
